Asia Pacific Metabolomics Market Research Report - Segmented By Product, Indication, Application & Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore & Rest of APAC) - Industry Analysis, Size, Share, Trends & Growth Forecast (2024 to 2029)

Updated On: June, 2024
ID: 3321
Pages: 175

APAC Metabolomics Market Size (2024 to 2029)

The Asia Pacific Metabolomics Market Size is valued at USD 556.21 Million in 2024 and estimated to grow at a CAGR of 17.92%, to reach USD 1268.15 Million by 2029 during the forecast period 2024 - 2029.

Metabolomics is the rational study of concoction forms comprising metabolites. In particular, metabolomics is the "deliberate investigation of the one of a kind synthetic fingerprints that particular cell forms desert", the study of their little molecules metabolite profiles. The metabolome signifies to the accumulation of all metabolites in natural fleshy tissue, cell, organ or life form, which are the final consequences of cell processes. The Asia Pacific Metabolomics market is developing at a very quick speed.

The increasing biotech ground-breaking work and pharmaceutical consumption are prompting persistent headways in innovation, spelling development for the worldwide metabolomics market. The developing acceptance of metabolomics in customized medicines is one of the key variables boosting the growth of the market. Then again, there are issues with respect to information handling and information examination, which can represent a test for the market. The high cost of instruments and devices can equally be an issue. Further, the necessity for very much skilled specialists and the absence of the same is limiting the improvement of the metabolomics market.

This research report on the Asia-Pacific Metabolomics Market has been segmented and sub-segmented into the following categories:

APAC Metabolomics Market Analysis By Product

  • GC
  • Bioinformatics
  • Mass Spectrometry
  • HPLC
  • UPLC
  • NMRS
  • Surface-based mass analysis

APAC Metabolomics Market Analysis By Indication

  • Oncology
  • Cardiology
  • Inborn Error

APAC Metabolomics Market Analysis By Application

  • Nutrigenomics
  • Toxicology
  • Biomarker 
  • Drug Discovery

APAC Metabolomics Market Analysis By Country

  • India
  • China
  • Japan
  • South Korea
  • Australia
  • New Zealand
  • Thailand
  • Malaysia
  • Vietnam
  • Philippines
  • Indonesia
  • Singapore
  • Rest of APAC

On the basis of application, the Biomarker Discovery segment had the largest share in 2016 in the global metabolomics market. Efficiency and reliability have been cited as the reason for the growth of biomarkers. However, collaboration between biotechnology and pharmaceutical companies, the personalized medical segment is expected to have the highest CAGR.

On the basis of region, China and India are likely to increase the market because of the huge population. Also, Asia Pacific is the largest growing segment.

Noteworthy companies leading the Asia Pacific Metabolomics Market analyzed in this report are Agilent Technologies, Inc. (U.S.), Human Metabolome Technologies, Inc. (Japan), Thermo Fisher Scientific, Inc. (U.S.), LECO Corporation (U.S.), Bruker Corporation (U.S.), Shimadzu Corporation (Japan), Metabolon Inc. (U.S.), Danaher Corporation (U.S.), Biocrates Life Sciences AG (Austria), and Waters Corporation (U.S.).

Please wait. . . . Your request is being processed

Anil Kumar P is research manager at Market Data Forecast and responsible for Healthcare Domain.

Author

Anil Kumar P (Research Manager - Healthcare)

Anil Kumar P is the lead author of this report and the manager of the team responsible for authoring healthcare reports at Market Data Forecast. He holds a Bachelor’s degree in Pharmacy (Hons.) from BITS Pilani, one of India’s premier institutions. Over the past seven years, Anil has gained extensive experience working with multiple market research companies, where he has collaborated with a diverse range of clients—from innovative startups to Fortune 500 companies—delivering data-driven insights and strategic advice that drive business growth.

Read More

Related Reports

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 1400

Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM

Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!

REACH OUT TO US

Call us on: +1 888 702 9696 (U.S Toll Free)

Write to us: [email protected]

Click for Request Sample